| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 146.61 | USD -3,665 | The ETF sold 25 shares of DVA on 2025-04-07. The shares were previously bought for an average price of USD 156.212. The DaVita HealthCare Partners Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 240 The average price that the ETF previously sold DVA share for is USD 155.271 which is higher than the selling price of USD 146.61 on 2025-04-07. |
| CRL - Creightons Plc | SELL | -28 @ USD 134.07 | USD -3,754 | The ETF sold 28 shares of CRL on 2025-04-07. The shares were previously bought for an average price of USD 171.177. The Creightons Plc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,039 The average price that the ETF previously sold CRL share for is USD 196.633 which is higher than the selling price of USD 134.07 on 2025-04-07. |
| HSIC - Henry Schein Inc | SELL | -67 @ USD 64.31 | USD -4,309 | The ETF sold 67 shares of HSIC on 2025-04-07. The shares were previously bought for an average price of USD 73.4903. The Henry Schein Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 615 The average price that the ETF previously sold HSIC share for is USD 72.1395 which is higher than the selling price of USD 64.31 on 2025-04-07. |
| TECH - Bio-Techne Corp | SELL | -85 @ USD 52.31 | USD -4,446 | The ETF sold 85 shares of TECH on 2025-04-07. The shares were previously bought for an average price of USD 67.0223. The Bio-Techne Corp shares were sold for -22.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,251 The average price that the ETF previously sold TECH share for is USD 72.3097 which is higher than the selling price of USD 52.31 on 2025-04-07. |
| MRNA - Moderna Inc | SELL | -179 @ USD 25.64 | USD -4,590 | The ETF sold 179 shares of MRNA on 2025-04-07. The shares were previously bought for an average price of USD 36.4077. The Moderna Inc shares were sold for -29.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,927 The average price that the ETF previously sold MRNA share for is USD 43.0387 which is higher than the selling price of USD 25.64 on 2025-04-07. |
| SOLV - Solventum Corp. | SELL | -72 @ USD 65.32 | USD -4,703 | The ETF sold 72 shares of SOLV on 2025-04-07. The shares were previously bought for an average price of USD 74.7865. The Solventum Corp. shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 682 The average price that the ETF previously sold SOLV share for is USD 71.5769 which is higher than the selling price of USD 65.32 on 2025-04-07. |
| VTRS - Viatris Inc | SELL | -646 @ USD 7.61 | USD -4,916 | The ETF sold 646 shares of VTRS on 2025-04-07. The shares were previously bought for an average price of USD 10.5684. The Viatris Inc shares were sold for -28.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,911 The average price that the ETF previously sold VTRS share for is USD 12.4658 which is higher than the selling price of USD 7.61 on 2025-04-07. |
| INCY - Incyte Corporation | SELL | -87 @ USD 60.29 | USD -5,245 | The ETF sold 87 shares of INCY on 2025-04-07. The shares were previously bought for an average price of USD 69.7854. The Incyte Corporation shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 826 The average price that the ETF previously sold INCY share for is USD 74.6318 which is higher than the selling price of USD 60.29 on 2025-04-07. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 171.67 | USD -5,322 | The ETF sold 31 shares of UHS on 2025-04-07. The shares were previously bought for an average price of USD 190.165. The Universal Health Services Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 573 The average price that the ETF previously sold UHS share for is USD 197.094 which is higher than the selling price of USD 171.67 on 2025-04-07. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 153.35 | USD -5,981 | The ETF sold 39 shares of ALGN on 2025-04-07. The shares were previously bought for an average price of USD 190.424. The Align Technology Inc shares were sold for -19.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,446 The average price that the ETF previously sold ALGN share for is USD 221.218 which is higher than the selling price of USD 153.35 on 2025-04-07. |
| RVTY - Revvity Inc. | SELL | -67 @ USD 96.16 | USD -6,443 | The ETF sold 67 shares of RVTY on 2025-04-07. The shares were previously bought for an average price of USD 113.763. The Revvity Inc. shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,179 The average price that the ETF previously sold RVTY share for is USD 116.689 which is higher than the selling price of USD 96.16 on 2025-04-07. |
| HOLX - Hologic Inc | SELL | -121 @ USD 61.27 | USD -7,414 | The ETF sold 121 shares of HOLX on 2025-04-07. The shares were previously bought for an average price of USD 67.8373. The Hologic Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 795 The average price that the ETF previously sold HOLX share for is USD 73.4004 which is higher than the selling price of USD 61.27 on 2025-04-07. |
| BAX - Baxter International Inc | SELL | -274 @ USD 28.64 | USD -7,847 | The ETF sold 274 shares of BAX on 2025-04-07. The shares were previously bought for an average price of USD 33.5164. The Baxter International Inc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,336 The average price that the ETF previously sold BAX share for is USD 33.5492 which is higher than the selling price of USD 28.64 on 2025-04-07. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 201.47 | USD -7,857 | The ETF sold 39 shares of WST on 2025-04-07. The shares were previously bought for an average price of USD 264.303. The West Pharmaceutical Services Inc shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,450 The average price that the ETF previously sold WST share for is USD 306.468 which is higher than the selling price of USD 201.47 on 2025-04-07. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -110 @ USD 73.31 | USD -8,064 | The ETF sold 110 shares of COO on 2025-04-07. The shares were previously bought for an average price of USD 89.8782. The The Cooper Companies, Inc. Common Stock shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,823 The average price that the ETF previously sold COO share for is USD 99.1299 which is higher than the selling price of USD 73.31 on 2025-04-07. |
| BIIB - Biogen Inc | SELL | -79 @ USD 119.19 | USD -9,416 | The ETF sold 79 shares of BIIB on 2025-04-07. The shares were previously bought for an average price of USD 147.936. The Biogen Inc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,271 The average price that the ETF previously sold BIIB share for is USD 161.907 which is higher than the selling price of USD 119.19 on 2025-04-07. |
| PODD - Insulet Corporation | SELL | -38 @ USD 256.23 | USD -9,737 | The ETF sold 38 shares of PODD on 2025-04-07. The shares were previously bought for an average price of USD 269.561. The Insulet Corporation shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 507 The average price that the ETF previously sold PODD share for is USD 262.211 which is higher than the selling price of USD 256.23 on 2025-04-07. |
| DGX - Quest Diagnostics Incorporated | SELL | -61 @ USD 164.31 | USD -10,023 | The ETF sold 61 shares of DGX on 2025-04-07. The shares were previously bought for an average price of USD 165.734. The Quest Diagnostics Incorporated shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 87 The average price that the ETF previously sold DGX share for is USD 160.934 so the ETF has sold 61 shares on 2025-04-07 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 223.5 | USD -10,058 | The ETF sold 45 shares of LH on 2025-04-07. The shares were previously bought for an average price of USD 241.657. The Laboratory Corporation of America Holdings shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 817 The average price that the ETF previously sold LH share for is USD 238.385 which is higher than the selling price of USD 223.5 on 2025-04-07. |
| MOH - MOH | SELL | -30 @ USD 340.38 | USD -10,211 | The ETF sold 30 shares of MOH on 2025-04-07. The shares were previously bought for an average price of USD 307.818. The MOH shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 977 The average price that the ETF previously sold MOH share for is USD 312.466 so the ETF has sold 30 shares on 2025-04-07 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 340.38 | USD -10,211 | The ETF sold 30 shares of MOH on 2025-04-07. The shares were previously bought for an average price of USD 307.818. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 977 The average price that the ETF previously sold MOH share for is USD 312.466 so the ETF has sold 30 shares on 2025-04-07 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 325.8 | USD -10,426 | The ETF sold 32 shares of WAT on 2025-04-07. The shares were previously bought for an average price of USD 373.416. The Waters Corporation shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,524 The average price that the ETF previously sold WAT share for is USD 376.811 which is higher than the selling price of USD 325.8 on 2025-04-07. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 325.8 | USD -10,426 | The ETF sold 32 shares of WAT on 2025-04-07. The shares were previously bought for an average price of USD 373.416. The MULETFWATIMETFP shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,524 The average price that the ETF previously sold WAT share for is USD 376.811 which is higher than the selling price of USD 325.8 on 2025-04-07. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -107 @ USD 104.84 | USD -11,218 | The ETF sold 107 shares of ZBH on 2025-04-07. The shares were previously bought for an average price of USD 107.997. The Zimmer Biomet Holdings Inc shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 338 The average price that the ETF previously sold ZBH share for is USD 109.215 which is higher than the selling price of USD 104.84 on 2025-04-07. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1032.15 | USD -11,354 | The ETF sold 11 shares of MTD on 2025-04-07. The shares were previously bought for an average price of USD 1258.05. The Mettler-Toledo International Inc shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,485 The average price that the ETF previously sold MTD share for is USD 1258.59 which is higher than the selling price of USD 1032.15 on 2025-04-07. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1032.15 | USD -11,354 | The ETF sold 11 shares of MTD on 2025-04-07. The shares were previously bought for an average price of USD 1258.05. The AMUNDI EUR GOV 710 shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,485 The average price that the ETF previously sold MTD share for is USD 1258.59 which is higher than the selling price of USD 1032.15 on 2025-04-07. |
| STE - STERIS plc | SELL | -54 @ USD 212.76 | USD -11,489 | The ETF sold 54 shares of STE on 2025-04-07. The shares were previously bought for an average price of USD 221.717. The STERIS plc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 484 The average price that the ETF previously sold STE share for is USD 218.038 which is higher than the selling price of USD 212.76 on 2025-04-07. |
| DXCM - DexCom Inc | SELL | -212 @ USD 61.63 | USD -13,066 | The ETF sold 212 shares of DXCM on 2025-04-07. The shares were previously bought for an average price of USD 78.5289. The DexCom Inc shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,583 The average price that the ETF previously sold DXCM share for is USD 74.3371 which is higher than the selling price of USD 61.63 on 2025-04-07. |
| IQV - IQVIA Holdings Inc | SELL | -91 @ USD 153.01 | USD -13,924 | The ETF sold 91 shares of IQV on 2025-04-07. The shares were previously bought for an average price of USD 196.411. The IQVIA Holdings Inc shares were sold for -22.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,949 The average price that the ETF previously sold IQV share for is USD 201.951 which is higher than the selling price of USD 153.01 on 2025-04-07. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -246 @ USD 60.99 | USD -15,004 | The ETF sold 246 shares of GEHC on 2025-04-07. The shares were previously bought for an average price of USD 86.443. The GE HealthCare Technologies Inc. shares were sold for -29.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,261 The average price that the ETF previously sold GEHC share for is USD 83.3348 which is higher than the selling price of USD 60.99 on 2025-04-07. |
| A - Agilent Technologies Inc | SELL | -155 @ USD 103.59 | USD -16,056 | The ETF sold 155 shares of A on 2025-04-07. The shares were previously bought for an average price of USD 131.964. The Agilent Technologies Inc shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,398 The average price that the ETF previously sold A share for is USD 134.496 which is higher than the selling price of USD 103.59 on 2025-04-07. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 254.71 | USD -16,556 | The ETF sold 65 shares of HUM on 2025-04-07. The shares were previously bought for an average price of USD 272.131. The Hummingbird Resources PLC shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,132 The average price that the ETF previously sold HUM share for is USD 282.994 which is higher than the selling price of USD 254.71 on 2025-04-07. |
| HUM - Humana Inc | SELL | -65 @ USD 254.71 | USD -16,556 | The ETF sold 65 shares of HUM on 2025-04-07. The shares were previously bought for an average price of USD 272.131. The Humana Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,132 The average price that the ETF previously sold HUM share for is USD 282.994 which is higher than the selling price of USD 254.71 on 2025-04-07. |
| CAH - Cardinal Health Inc | SELL | -132 @ USD 125.68 | USD -16,590 | The ETF sold 132 shares of CAH on 2025-04-07. The shares were previously bought for an average price of USD 127.212. The Cardinal Health Inc shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 202 The average price that the ETF previously sold CAH share for is USD 122.091 so the ETF has sold 132 shares on 2025-04-07 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -271 @ USD 61.35 | USD -16,626 | The ETF sold 271 shares of CNC on 2025-04-07. The shares were previously bought for an average price of USD 60.1823. The Concurrent Technologies Plc shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 316 The average price that the ETF previously sold CNC share for is USD 59.7457 so the ETF has sold 271 shares on 2025-04-07 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 378.99 | USD -16,676 | The ETF sold 44 shares of IDXX on 2025-04-07. The shares were previously bought for an average price of USD 438.202. The IDEXX Laboratories Inc shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,605 The average price that the ETF previously sold IDXX share for is USD 430.674 which is higher than the selling price of USD 378.99 on 2025-04-07. |
| RMD - ResMed Inc | SELL | -80 @ USD 213 | USD -17,040 | The ETF sold 80 shares of RMD on 2025-04-07. The shares were previously bought for an average price of USD 235.04. The ResMed Inc shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,763 The average price that the ETF previously sold RMD share for is USD 244.157 which is higher than the selling price of USD 213 on 2025-04-07. |
| EW - Edwards Lifesciences Corp | SELL | -320 @ USD 69 | USD -22,080 | The ETF sold 320 shares of EW on 2025-04-07. The shares were previously bought for an average price of USD 71.0156. The Edwards Lifesciences Corp shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 645 The average price that the ETF previously sold EW share for is USD 69.3791 which is higher than the selling price of USD 69 on 2025-04-07. |
| COR - Cencora Inc. | SELL | -94 @ USD 274.56 | USD -25,809 | The ETF sold 94 shares of COR on 2025-04-07. The shares were previously bought for an average price of USD 251.231. The Cencora Inc. shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 2,193 The average price that the ETF previously sold COR share for is USD 247.492 so the ETF has sold 94 shares on 2025-04-07 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 329.63 | USD -31,974 | The ETF sold 97 shares of HCA on 2025-04-07. The shares were previously bought for an average price of USD 336.277. The HCA Holdings Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 645 The average price that the ETF previously sold HCA share for is USD 335.614 which is higher than the selling price of USD 329.63 on 2025-04-07. |
| BDX - Becton Dickinson and Company | SELL | -156 @ USD 205.08 | USD -31,992 | The ETF sold 156 shares of BDX on 2025-04-07. The shares were previously bought for an average price of USD 231.159. The Becton Dickinson and Company shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,068 The average price that the ETF previously sold BDX share for is USD 226.377 which is higher than the selling price of USD 205.08 on 2025-04-07. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 572.78 | USD -32,648 | The ETF sold 57 shares of REGN on 2025-04-07. The shares were previously bought for an average price of USD 714.539. The Regeneron Pharmaceuticals Inc shares were sold for -19.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,080 The average price that the ETF previously sold REGN share for is USD 776.618 which is higher than the selling price of USD 572.78 on 2025-04-07. |
| ZTS - Zoetis Inc | SELL | -243 @ USD 149.1 | USD -36,231 | The ETF sold 243 shares of ZTS on 2025-04-07. The shares were previously bought for an average price of USD 168.289. The Zoetis Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,663 The average price that the ETF previously sold ZTS share for is USD 175.864 which is higher than the selling price of USD 149.1 on 2025-04-07. |
| CVS - CVS Health Corp | SELL | -684 @ USD 63.85 | USD -43,673 | The ETF sold 684 shares of CVS on 2025-04-07. The shares were previously bought for an average price of USD 62.1919. The CVS Health Corp shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 1,134 The average price that the ETF previously sold CVS share for is USD 57.658 so the ETF has sold 684 shares on 2025-04-07 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 661.97 | USD -45,014 | The ETF sold 68 shares of MCK on 2025-04-07. The shares were previously bought for an average price of USD 612.44. The McKesson Corporation shares were sold for 8.1% higher than average price of previous purchases. This sale made a profit of USD 3,368 The average price that the ETF previously sold MCK share for is USD 609.032 so the ETF has sold 68 shares on 2025-04-07 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 315.39 | USD -46,993 | The ETF sold 149 shares of CI on 2025-04-07. The shares were previously bought for an average price of USD 313.959. The Cigna Corp shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of USD 213 The average price that the ETF previously sold CI share for is USD 322.66 which is higher than the selling price of USD 315.39 on 2025-04-07. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 423.14 | USD -53,316 | The ETF sold 126 shares of ELV on 2025-04-07. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 1,696 The average price that the ETF previously sold ELV share for is USD 409.979 so the ETF has sold 126 shares on 2025-04-07 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 423.14 | USD -53,316 | The ETF sold 126 shares of ELV on 2025-04-07. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 1,696 The average price that the ETF previously sold ELV share for is USD 409.979 so the ETF has sold 126 shares on 2025-04-07 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -697 @ USD 83.15 | USD -57,956 | The ETF sold 697 shares of MDT on 2025-04-07. The shares were previously bought for an average price of USD 89.1446. The Medtronic PLC shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,178 The average price that the ETF previously sold MDT share for is USD 86.8364 which is higher than the selling price of USD 83.15 on 2025-04-07. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,102 @ USD 55.19 | USD -60,819 | The ETF sold 1102 shares of BMY on 2025-04-07. The shares were previously bought for an average price of USD 58.1196. The Bloomsbury Publishing Plc shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,228 The average price that the ETF previously sold BMY share for is USD 57.1771 which is higher than the selling price of USD 55.19 on 2025-04-07. |
| DHR - Danaher Corporation | SELL | -348 @ USD 180.62 | USD -62,856 | The ETF sold 348 shares of DHR on 2025-04-07. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 13,651 The average price that the ETF previously sold DHR share for is USD 235.823 which is higher than the selling price of USD 180.62 on 2025-04-07. |
| DHR - Danaher Corporation | SELL | -348 @ USD 180.62 | USD -62,856 | The ETF sold 348 shares of DHR on 2025-04-07. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 13,651 The average price that the ETF previously sold DHR share for is USD 235.823 which is higher than the selling price of USD 180.62 on 2025-04-07. |
| SYK - Stryker Corporation | SELL | -187 @ USD 345.34 | USD -64,579 | The ETF sold 187 shares of SYK on 2025-04-07. The shares were previously bought for an average price of USD 380.929. The Stryker Corporation shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,655 The average price that the ETF previously sold SYK share for is USD 379.738 which is higher than the selling price of USD 345.34 on 2025-04-07. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 474.56 | USD -65,964 | The ETF sold 139 shares of VRTX on 2025-04-07. The shares were previously bought for an average price of USD 477.045. The Vertex Pharmaceuticals Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 345 The average price that the ETF previously sold VRTX share for is USD 480.95 which is higher than the selling price of USD 474.56 on 2025-04-07. |
| PFE - Pfizer Inc | SELL | -3,075 @ USD 22.63 | USD -69,587 | The ETF sold 3075 shares of PFE on 2025-04-07. The shares were previously bought for an average price of USD 26.0678. The Pfizer Inc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 10,571 The average price that the ETF previously sold PFE share for is USD 26.1008 which is higher than the selling price of USD 22.63 on 2025-04-07. |
| GILD - Guild Esports Plc | SELL | -676 @ USD 105.52 | USD -71,332 | The ETF sold 676 shares of GILD on 2025-04-07. The shares were previously bought for an average price of USD 102.556. The Guild Esports Plc shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 2,004 The average price that the ETF previously sold GILD share for is USD 94.3931 so the ETF has sold 676 shares on 2025-04-07 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -801 @ USD 91.54 | USD -73,324 | The ETF sold 801 shares of BSX on 2025-04-07. The shares were previously bought for an average price of USD 98.4985. The Boston Scientific Corporation shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,574 The average price that the ETF previously sold BSX share for is USD 90.0182 so the ETF has sold 801 shares on 2025-04-07 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -801 @ USD 91.54 | USD -73,324 | The ETF sold 801 shares of BSX on 2025-04-07. The shares were previously bought for an average price of USD 98.4985. The MULSTRXSSXIMETFP shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,574 The average price that the ETF previously sold BSX share for is USD 90.0182 so the ETF has sold 801 shares on 2025-04-07 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 289.69 | USD -84,589 | The ETF sold 292 shares of AMGN on 2025-04-07. The shares were previously bought for an average price of USD 304.248. The Amgen Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,251 The average price that the ETF previously sold AMGN share for is USD 298.296 which is higher than the selling price of USD 289.69 on 2025-04-07. |
| ISRG - Intuitive Surgical Inc | SELL | -194 @ USD 463.62 | USD -89,942 | The ETF sold 194 shares of ISRG on 2025-04-07. The shares were previously bought for an average price of USD 546.225. The Intuitive Surgical Inc shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 16,025 The average price that the ETF previously sold ISRG share for is USD 533.302 which is higher than the selling price of USD 463.62 on 2025-04-07. |
| TMO - Time Out Group plc | SELL | -208 @ USD 437.87 | USD -91,077 | The ETF sold 208 shares of TMO on 2025-04-07. The shares were previously bought for an average price of USD 532.898. The Time Out Group plc shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 19,766 The average price that the ETF previously sold TMO share for is USD 531.391 which is higher than the selling price of USD 437.87 on 2025-04-07. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 81.18 | USD -111,623 | The ETF sold 1375 shares of MRK on 2025-04-07. The shares were previously bought for an average price of USD 93.1573. The Marks Electrical Group PLC shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 16,469 The average price that the ETF previously sold MRK share for is USD 100.459 which is higher than the selling price of USD 81.18 on 2025-04-07. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 81.18 | USD -111,623 | The ETF sold 1375 shares of MRK on 2025-04-07. The shares were previously bought for an average price of USD 93.1573. The Merck & Company Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 16,469 The average price that the ETF previously sold MRK share for is USD 100.459 which is higher than the selling price of USD 81.18 on 2025-04-07. |
| ABT - Abbott Laboratories | SELL | -941 @ USD 124.86 | USD -117,493 | The ETF sold 941 shares of ABT on 2025-04-07. The shares were previously bought for an average price of USD 126.267. The Abbott Laboratories shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,324 The average price that the ETF previously sold ABT share for is USD 117.944 so the ETF has sold 941 shares on 2025-04-07 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -959 @ USD 186.55 | USD -178,901 | The ETF sold 959 shares of ABBV on 2025-04-07. The shares were previously bought for an average price of USD 193.27. The AbbVie Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,444 The average price that the ETF previously sold ABBV share for is USD 187.064 which is higher than the selling price of USD 186.55 on 2025-04-07. |
| JNJ - Johnson & Johnson | SELL | -1,308 @ USD 150.62 | USD -197,011 | The ETF sold 1308 shares of JNJ on 2025-04-07. The shares were previously bought for an average price of USD 157.739. The Johnson & Johnson shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,312 The average price that the ETF previously sold JNJ share for is USD 155.005 which is higher than the selling price of USD 150.62 on 2025-04-07. |
| UNH - UnitedHealth Group Incorporated | SELL | -500 @ USD 524.7 | USD -262,350 | The ETF sold 500 shares of UNH on 2025-04-07. The shares were previously bought for an average price of USD 535.348. The UnitedHealth Group Incorporated shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,324 The average price that the ETF previously sold UNH share for is USD 582.739 which is higher than the selling price of USD 524.7 on 2025-04-07. |
| LLY - Eli Lilly and Company | SELL | -428 @ USD 723.73 | USD -309,756 | The ETF sold 428 shares of LLY on 2025-04-07. The shares were previously bought for an average price of USD 838.12. The Eli Lilly and Company shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 48,959 The average price that the ETF previously sold LLY share for is USD 803.996 which is higher than the selling price of USD 723.73 on 2025-04-07. |